O	O	O	0	3	One	One	B-NP	CD	O	2	NMOD	O
O	O	O	4	8	gene	gene	I-NP	NN	O	5	NMOD	O
O	O	O	8	9	,	,	O	,	O	5	P	O
O	O	O	10	13	two	two	B-NP	CD	O	5	NMOD	O
O	O	O	14	25	transcripts	transcript	I-NP	NNS	B-RNA	0	ROOT	B-RNA
O	O	O	25	26	:	:	O	:	O	5	P	O
O	O	O	27	36	isolation	isolation	B-NP	NN	O	5	NMOD	O
O	O	O	37	39	of	of	B-PP	IN	O	7	NMOD	O
O	O	O	40	42	an	an	B-NP	DT	O	11	NMOD	O
O	O	O	43	54	alternative	alternative	I-NP	JJ	B-RNA	11	NMOD	B-RNA
O	O	O	55	65	transcript	transcript	I-NP	NN	I-RNA	8	PMOD	I-RNA
O	O	O	66	74	encoding	encode	B-VP	VBG	O	11	NMOD	O
O	O	O	75	78	for	for	B-PP	IN	O	12	VMOD	O
O	O	O	79	82	the	the	B-NP	DT	O	20	NMOD	O
T1	B-Protein	B-Protein	83	94	autoantigen	autoantigen	I-NP	NN	O	20	NMOD	O
T1	I-Protein	I-Protein	95	97	La	La	I-NP	NN	O	20	NMOD	O
O	O	O	97	98	/	/	B-NP	SYM	O	20	P	O
T2	B-Protein	B-Protein	98	100	SS	SS	I-NP	NN	B-protein	20	NMOD	B-protein
T2	I-Protein	I-Protein	100	101	-	-	B-NP	HYPH	I-protein	20	NMOD	I-protein
T2	I-Protein	I-Protein	101	102	B	B	I-NP	NN	I-protein	13	PMOD	I-protein
O	O	O	103	107	from	from	B-PP	IN	O	12	VMOD	O
O	O	O	108	109	a	a	B-NP	DT	O	24	NMOD	O
T10	B-Entity	B-Entity	110	114	cDNA	cDNA	I-NP	NN	B-DNA	24	NMOD	B-DNA
T10	I-Entity	I-Entity	115	122	library	library	I-NP	NN	I-DNA	21	PMOD	I-DNA
O	O	O	123	125	of	of	B-PP	IN	O	24	NMOD	O
O	O	O	126	127	a	a	B-NP	DT	O	27	NMOD	O
O	O	O	128	135	patient	patient	I-NP	NN	O	25	PMOD	O
O	O	O	136	140	with	with	B-PP	IN	O	27	NMOD	O
O	O	O	141	148	primary	primary	B-NP	JJ	O	32	NMOD	O
O	O	O	149	157	Sjogrens	Sjogrens	I-NP	NN	O	32	NMOD	O
O	O	O	157	158	'	'	B-NP	POS	O	32	NMOD	O
O	O	O	159	167	syndrome	syndrome	I-NP	NN	O	28	PMOD	O
O	O	O	167	168	.	.	O	.	O	5	P	O

O	O	O	170	171	A	A	B-NP	DT	O	3	NMOD	O
T11	B-Entity	B-Entity	172	176	cDNA	cDNA	I-NP	NN	B-DNA	3	NMOD	B-DNA
T11	I-Entity	I-Entity	177	184	library	library	I-NP	NN	I-DNA	4	SUB	I-DNA
O	O	O	185	188	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	189	197	prepared	prepare	I-VP	VBN	O	4	VC	O
O	O	O	198	202	from	from	B-PP	IN	O	5	VMOD	O
O	O	O	203	213	peripheral	peripheral	B-NP	JJ	B-cell_type	9	NMOD	B-cell_type
O	O	O	214	219	blood	blood	I-NP	NN	I-cell_type	9	NMOD	I-cell_type
O	O	O	220	231	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	6	PMOD	I-cell_type
O	O	O	232	234	of	of	B-PP	IN	O	9	NMOD	O
O	O	O	235	237	an	an	B-NP	DT	O	13	NMOD	O
O	O	O	238	248	autoimmune	autoimmune	I-NP	JJ	O	13	NMOD	O
O	O	O	249	256	patient	patient	I-NP	NN	O	10	PMOD	O
O	O	O	257	261	with	with	B-PP	IN	O	13	NMOD	O
O	O	O	262	269	primary	primary	B-NP	JJ	O	18	NMOD	O
O	O	O	270	278	Sjogrens	Sjogrens	I-NP	NN	O	18	NMOD	O
O	O	O	278	279	'	'	B-NP	POS	O	18	NMOD	O
O	O	O	280	288	syndrome	syndrome	I-NP	NN	O	14	PMOD	O
O	O	O	288	289	.	.	O	.	O	4	P	O

O	O	O	290	293	The	The	B-NP	DT	O	3	NMOD	O
T12	B-Entity	B-Entity	294	298	cDNA	cDNA	I-NP	NN	B-DNA	3	NMOD	B-DNA
T12	I-Entity	I-Entity	299	306	library	library	I-NP	NN	I-DNA	4	SUB	I-DNA
O	O	O	307	310	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	311	319	screened	screen	I-VP	VBN	O	4	VC	O
O	O	O	320	324	with	with	B-PP	IN	O	5	VMOD	O
O	O	O	325	328	the	the	B-NP	DT	O	8	NMOD	O
O	O	O	329	337	patients	patient	I-NP	NNS	O	6	PMOD	O
O	O	O	338	341	own	own	B-VP	VBP	O	12	VMOD	O
O	O	O	342	352	autoimmune	autoimmune	B-NP	JJ	O	11	NMOD	O
O	O	O	353	358	serum	serum	I-NP	NN	O	12	SUB	O
O	O	O	359	364	being	be	B-VP	VBG	O	4	VMOD	O
O	O	O	365	377	monospecific	monospecific	B-ADJP	JJ	O	12	PRD	O
O	O	O	378	381	for	for	B-PP	IN	O	13	AMOD	O
O	O	O	382	385	the	the	B-NP	DT	O	22	NMOD	O
O	O	O	386	393	nuclear	nuclear	I-NP	JJ	O	22	NMOD	O
T3	B-Protein	B-Protein	394	405	autoantigen	autoantigen	I-NP	NN	O	22	NMOD	O
T3	I-Protein	I-Protein	406	408	La	La	I-NP	NN	O	22	NMOD	O
O	O	O	408	409	/	/	B-NP	SYM	O	22	NMOD	O
T4	B-Protein	B-Protein	409	411	SS	SS	I-NP	NN	B-protein	22	NMOD	B-protein
T4	I-Protein	I-Protein	411	412	-	-	B-NP	HYPH	I-protein	22	NMOD	I-protein
T4	I-Protein	I-Protein	412	413	B	B	I-NP	NN	I-protein	14	PMOD	I-protein
O	O	O	413	414	.	.	O	.	O	4	P	O

O	O	O	415	422	Thereby	Thereby	B-ADVP	RB	O	8	VMOD	O
O	O	O	423	425	an	an	B-NP	DT	O	4	NMOD	O
O	O	O	426	437	alternative	alternative	I-NP	JJ	O	4	NMOD	O
O	O	O	438	442	type	type	I-NP	NN	O	8	SUB	O
O	O	O	443	445	of	of	B-PP	IN	O	4	NMOD	O
T5	B-Protein	B-Protein	446	448	La	La	B-NP	NN	B-RNA	7	NMOD	B-RNA
O	O	O	449	453	mRNA	mRNA	I-NP	NN	I-RNA	5	PMOD	I-RNA
O	O	O	454	457	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	458	468	identified	identify	I-VP	VBN	O	8	VC	O
O	O	O	469	473	that	that	B-NP	WDT	O	8	VMOD	O
O	O	O	474	482	differed	differ	B-VP	VBD	O	10	SBAR	O
O	O	O	483	487	from	from	B-PP	IN	O	11	VMOD	O
O	O	O	488	491	the	the	B-NP	DT	O	14	NMOD	O
O	O	O	492	497	known	know	I-NP	VBN	O	12	PMOD	O
T6	B-Protein	B-Protein	498	500	La	La	I-NP	NN	B-RNA	16	NMOD	B-RNA
O	O	O	501	505	mRNA	mRNA	I-NP	NN	I-RNA	14	NMOD	I-RNA
O	O	O	506	509	due	due	B-ADJP	JJ	O	11	VMOD	O
O	O	O	510	512	to	to	B-PP	TO	O	17	AMOD	O
O	O	O	513	515	an	an	B-NP	DT	O	20	NMOD	O
O	O	O	516	524	exchange	exchange	I-NP	NN	O	18	PMOD	O
O	O	O	525	527	of	of	B-PP	IN	O	20	NMOD	O
O	O	O	528	531	the	the	B-NP	DT	O	23	NMOD	O
T13	B-Entity	B-Entity	532	536	exon	exon	I-NP	NN	B-DNA	21	PMOD	B-DNA
T13	I-Entity	I-Entity	537	538	1	1	I-NP	CD	I-DNA	23	NMOD	I-DNA
O	O	O	538	539	.	.	O	.	O	8	P	O

O	O	O	540	550	Sequencing	Sequencing	B-NP	NN	O	12	SUB	O
O	O	O	551	553	of	of	B-PP	IN	O	1	NMOD	O
O	O	O	554	557	the	the	B-NP	DT	O	5	NMOD	O
O	O	O	558	565	genomic	genomic	I-NP	JJ	B-DNA	5	NMOD	B-DNA
O	O	O	566	572	region	region	I-NP	NN	I-DNA	2	PMOD	I-DNA
O	O	O	573	580	between	between	B-PP	IN	O	5	NMOD	O
O	O	O	581	584	the	the	B-NP	DT	O	8	NMOD	O
T14	B-Entity	B-Entity	585	590	exons	exon	I-NP	NNS	B-DNA	6	PMOD	B-DNA
T14	I-Entity	I-Entity	591	592	1	1	I-NP	CD	I-DNA	8	NMOD	I-DNA
O	O	O	593	596	and	and	I-NP	CC	I-DNA	8	NMOD	I-DNA
T15	B-Entity	B-Entity	597	598	2	2	I-NP	CD	I-DNA	8	NMOD	I-DNA
O	O	O	599	605	showed	show	B-VP	VBD	O	0	ROOT	O
O	O	O	606	610	that	that	B-SBAR	IN	O	12	VMOD	O
O	O	O	611	614	the	the	B-NP	DT	O	19	NMOD	O
T16	B-Entity	B-Entity	615	626	alternative	alternative	I-NP	JJ	B-DNA	19	NMOD	B-DNA
T16	I-Entity	I-Entity	627	628	5	5	I-NP	CD	I-DNA	19	NMOD	I-DNA
T16	I-Entity	I-Entity	628	629	'	'	I-NP	SYM	I-DNA	19	NMOD	I-DNA
T16	I-Entity	I-Entity	629	630	-	-	I-NP	HYPH	I-DNA	19	NMOD	I-DNA
T16	I-Entity	I-Entity	630	633	end	end	I-NP	NN	I-DNA	20	SUB	I-DNA
O	O	O	634	636	is	be	B-VP	VBZ	O	13	SBAR	O
O	O	O	637	638	a	a	B-NP	DT	O	22	NMOD	O
O	O	O	639	643	part	part	I-NP	NN	O	20	PRD	O
O	O	O	644	646	of	of	B-PP	IN	O	22	NMOD	O
O	O	O	647	650	the	the	B-NP	DT	O	25	NMOD	O
T17	B-Entity	B-Entity	651	657	intron	intron	I-NP	NN	B-DNA	23	PMOD	B-DNA
O	O	O	657	658	.	.	O	.	O	12	P	O

O	O	O	659	661	In	In	B-PP	IN	O	23	VMOD	O
O	O	O	662	670	addition	addition	B-NP	NN	O	1	PMOD	O
O	O	O	670	671	,	,	O	,	O	23	P	O
O	O	O	672	675	the	the	B-NP	DT	O	5	NMOD	O
O	O	O	676	684	presence	presence	I-NP	NN	O	23	SUB	O
O	O	O	685	687	of	of	B-PP	IN	O	5	NMOD	O
O	O	O	688	690	an	an	B-NP	DT	O	10	NMOD	O
T18	B-Entity	B-Entity	691	702	alternative	alternative	I-NP	JJ	B-DNA	10	NMOD	B-DNA
T18	I-Entity	I-Entity	703	711	promoter	promoter	I-NP	NN	I-DNA	10	NMOD	I-DNA
T18	I-Entity	I-Entity	712	716	site	site	I-NP	NN	I-DNA	6	PMOD	I-DNA
O	O	O	716	717	,	,	O	,	O	5	P	O
O	O	O	718	723	which	which	B-NP	WDT	O	5	NMOD	O
O	O	O	724	730	exists	exist	B-VP	VBZ	O	12	SBAR	O
O	O	O	731	737	within	within	B-PP	IN	O	13	VMOD	O
O	O	O	738	741	the	the	B-NP	DT	O	16	NMOD	O
T19	B-Entity	B-Entity	742	748	intron	intron	I-NP	NN	B-DNA	14	PMOD	B-DNA
O	O	O	749	759	downstream	downstream	B-ADVP	RB	O	16	NMOD	O
O	O	O	760	762	of	of	B-PP	IN	O	17	AMOD	O
O	O	O	763	766	the	the	B-NP	DT	O	20	NMOD	O
T20	B-Entity	B-Entity	767	771	exon	exon	I-NP	NN	B-DNA	18	PMOD	B-DNA
T20	I-Entity	I-Entity	772	773	1	1	I-NP	CD	I-DNA	20	NMOD	I-DNA
O	O	O	773	774	,	,	O	,	O	5	P	O
O	O	O	775	781	became	become	B-VP	VBD	O	0	ROOT	O
O	O	O	782	789	evident	evident	B-ADJP	JJ	O	23	PRD	O
O	O	O	789	790	.	.	O	.	O	23	P	O

O	O	O	791	793	In	In	B-PP	IN	O	8	VMOD	O
O	O	O	794	805	consequence	consequence	B-NP	NN	O	1	PMOD	O
O	O	O	805	806	,	,	O	,	O	8	P	O
O	O	O	807	810	the	the	B-NP	DT	O	7	NMOD	O
O	O	O	811	822	alternative	alternative	I-NP	JJ	B-RNA	7	NMOD	B-RNA
T7	B-Protein	B-Protein	823	825	La	La	I-NP	NN	I-RNA	7	NMOD	I-RNA
O	O	O	826	830	mRNA	mRNA	I-NP	NN	I-RNA	8	SUB	I-RNA
O	O	O	831	833	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	834	837	the	the	B-NP	DT	O	10	NMOD	O
O	O	O	838	844	result	result	I-NP	NN	O	8	PRD	O
O	O	O	845	847	of	of	B-PP	IN	O	10	NMOD	O
O	O	O	848	849	a	a	B-NP	DT	O	14	NMOD	O
O	O	O	850	858	promoter	promoter	I-NP	NN	O	14	NMOD	O
O	O	O	859	868	switching	switching	I-NP	NN	O	11	PMOD	O
O	O	O	869	877	combined	combine	B-VP	VBN	O	14	NMOD	O
O	O	O	878	882	with	with	B-PP	IN	O	15	VMOD	O
O	O	O	883	885	an	an	B-NP	DT	O	20	NMOD	O
O	O	O	886	897	alternative	alternative	I-NP	JJ	O	20	NMOD	O
O	O	O	898	906	splicing	splicing	I-NP	NN	O	20	NMOD	O
O	O	O	907	916	mechanism	mechanism	I-NP	NN	O	16	PMOD	O
O	O	O	916	917	.	.	O	.	O	8	P	O

O	O	O	918	920	In	In	B-PP	IN	O	19	VMOD	O
O	O	O	921	924	the	the	B-NP	DT	O	3	NMOD	O
O	O	O	925	931	intron	intron	I-NP	NN	B-DNA	1	PMOD	B-DNA
O	O	O	931	932	,	,	O	,	O	19	P	O
O	O	O	933	940	further	further	B-NP	JJ	O	9	NMOD	O
O	O	O	941	954	transcription	transcription	I-NP	NN	O	9	NMOD	O
O	O	O	955	961	factor	factor	I-NP	NN	O	9	NMOD	O
O	O	O	962	969	binding	binding	I-NP	NN	O	9	NMOD	O
O	O	O	970	975	sites	site	I-NP	NNS	O	19	SUB	O
O	O	O	975	976	,	,	O	,	O	9	P	O
O	O	O	977	986	including	include	B-PP	VBG	O	9	NMOD	O
O	O	O	987	988	a	a	B-NP	DT	O	17	NMOD	O
T21	B-Entity	B-Entity	989	991	NF	NF	I-NP	NN	B-DNA	17	NMOD	B-DNA
T21	I-Entity	I-Entity	991	992	-	-	B-NP	HYPH	I-DNA	17	NMOD	I-DNA
T21	I-Entity	I-Entity	992	997	kappa	kappa	I-NP	NN	I-DNA	17	NMOD	I-DNA
T21	I-Entity	I-Entity	998	999	B	B	I-NP	NN	I-DNA	17	NMOD	I-DNA
T21	I-Entity	I-Entity	1000	1007	element	element	I-NP	NN	I-DNA	11	PMOD	I-DNA
O	O	O	1007	1008	,	,	O	,	O	9	P	O
O	O	O	1009	1013	were	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1014	1024	identified	identify	I-VP	VBN	O	19	VC	O
O	O	O	1025	1032	leading	lead	B-VP	VBG	O	20	VMOD	O
O	O	O	1033	1035	to	to	B-PP	TO	O	21	VMOD	O
O	O	O	1036	1039	the	the	B-NP	DT	O	24	NMOD	O
O	O	O	1040	1050	suggestion	suggestion	I-NP	NN	O	22	PMOD	O
O	O	O	1051	1055	that	that	B-SBAR	IN	O	24	NMOD	O
O	O	O	1056	1059	the	the	B-NP	DT	O	27	NMOD	O
O	O	O	1060	1070	expression	expression	I-NP	NN	O	25	SBAR	O
O	O	O	1071	1073	of	of	B-PP	IN	O	27	NMOD	O
O	O	O	1074	1077	the	the	B-NP	DT	O	30	NMOD	O
O	O	O	1078	1082	gene	gene	I-NP	NN	O	28	PMOD	O
O	O	O	1083	1091	encoding	encode	B-VP	VBG	O	30	NMOD	O
O	O	O	1092	1095	for	for	B-PP	IN	O	31	VMOD	O
O	O	O	1096	1099	the	the	B-NP	DT	O	41	NMOD	O
O	O	O	1100	1107	nuclear	nuclear	I-NP	JJ	O	41	NMOD	O
T8	B-Protein	B-Protein	1108	1119	autoantigen	autoantigen	I-NP	NN	O	41	NMOD	O
T8	I-Protein	I-Protein	1120	1122	La	La	I-NP	NN	O	41	NMOD	O
O	O	O	1122	1123	/	/	B-NP	SYM	O	41	P	O
T9	B-Protein	B-Protein	1123	1125	SS	SS	I-NP	NN	O	41	NMOD	O
T9	I-Protein	I-Protein	1125	1126	-	-	B-NP	HYPH	O	41	NMOD	O
T9	I-Protein	I-Protein	1126	1127	B	B	I-NP	NN	O	41	NMOD	O
O	O	O	1128	1134	alters	alter	I-NP	NNS	O	32	PMOD	O
O	O	O	1135	1137	in	in	B-PP	IN	O	31	VMOD	O
O	O	O	1138	1148	dependence	dependence	B-NP	NN	O	42	PMOD	O
O	O	O	1149	1151	on	on	B-PP	IN	O	43	NMOD	O
O	O	O	1152	1159	disease	disease	B-NP	NN	O	46	NMOD	O
O	O	O	1160	1170	conditions	condition	I-NP	NNS	O	44	PMOD	O
O	O	O	1170	1171	.	.	O	.	O	19	P	O
